Senate Finance Committee Democrat members wrote a letter to CMS addressing concerns about a new program for Medicare Part B to pay for prescription drugs, according to Morning Consult.
Here are five takeaways:
1. The program is designed to implement a value-based payment model for prescription drugs.
2. Democrats are concerned the new program will impact Medicare beneficiaries' access to care and physician-administered drugs.
3. They caution CMS to consider the disruptions a new program may cause for patients with complex conditions.
4. CMS has said beneficiaries will have access to Part B medications. Also, CMS will analyze how the initiative would impact ongoing delivery and payment reform models.
5. CMS also seeks more stakeholder engagement before implementing the new program.